Dhar, Payal http://orcid.org/0000-0001-5379-8675
Basher, Fahmin
Ji, Zhe http://orcid.org/0000-0002-1809-8099
Huang, Lei
Qin, Si
Wainwright, Derek A. http://orcid.org/0000-0001-7232-4264
Robinson, Jerid
Hagler, Shaye
Zhou, Jing
MacKay, Sean
Wu, Jennifer D. http://orcid.org/0000-0002-8925-268X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R01CA208246, 1R01CA204021, 1R01CA212409)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 19 December 2020
Accepted: 5 July 2021
First Online: 22 July 2021
Competing interests
: J.D.W. is the inventor of the B10G5 antibody with international patents. J.Z. is employed by and has equity ownership in IsoPlexis; S.M. is cofounder of, has equity ownership in, and holds patents with IsoPlexis. The remaining authors declare no competing interests.